Skip to main content

Table 1 Clinical and biochemical profiles for non-diabetics and T2D subjects

From: Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects

Variables

Normal (n = 535)

T2D (n = 214)

P value

Age (years)

41.3 ± 10.1

50.5 ± 9.8

<0.0001

Ethnicity

 Arab

285 (53.3 %)

110 (51.4 %)

 

 South Asian

250 (46.7 %)

104 (49.6 %)

 

BMI (kg/m2)

29.36 ± 6.23

30.72 ± 5.59

0.0039

Waist/hip ratio

0.91 ± 0.11

0.95 ± 0.06

<0.0001

Systolic (mmHg)

128.6 ± 17.9

138.7 ± 19.7

<0.0001

Diastolic (mmHg)

78.9 ± 12.2

81.4 ± 11.4

0.0083

FBG (mmol/L)

5.02 ± 0.58

8.91 ± 3.60

<0.0001

HBA1C (DCCT %)

5.47 ± 0.70

7.79 ± 2.09

<0.0001

Insulin (mU/L)

9.72 ± 6.23

20.43 ± 41.87

0.0003

HOMAIR

2.22 ± 1.60

8.03 ± 17.66

<0.0001

Total cholesterol (mmol/L)

5.17 ± 1.09

5.13 ± 1.07

0.5694

Triglycerides (mmol/L)

1.50 ± 0.87

2.04 ± 1.47

<0.0001

HDL cholesterol (mmol/L)

1.14 ± 0.33

1.06 ± 0.28

0.0022

LDL cholesterol (mmol/L)

3.40 ± 0.99

3.21 ± 0.94

0.0154

Betatrophin (pg/mL)

720.3 (59.5–9345.1)

(1710.1 (197.4–10972.1)

<0.0001

C peptide

606.2 ± 300.1

744.1 ± 419.0

<0.0001

  1. Results are reported as Mean ± SD except for non-normally distributed betatrophin that are presented as Median (range). Diabetes: fasting plasma glucose ≥ 7 mmol/l, under treatment, or self-reported of previously diagnosed T2D